Westlake Therapeutics
Latest round
- Series A
Last raised
- Jun 2022
Total raised
- $15M
Investors
- 8
About Westlake Therapeutics
, trading as Westlake Therapeutics, is a cell therapy company that focuses on the research and development of blood cell products. he company's team members mainly come from domestic and foreign research institutions, and have accumulated rich technical experience in the field; the company has a 2,800-square-meter R&D center in Hangzhou Yunqi Town, and was recognized as a national high-tech enterprise in 2022. Dr. Xiaofei Gao, the founder of the company, received his PhD from the University of Kansas and completed his postdoctoral research at the Massachusetts Institute of Technology in the United States. The company engages in the research and development of RBC-based cellular medicine. Its product pipeline includes lung cancer, cervical cancer, gout and sepsis, etc. The company's red blood cell engineering platform can produce therapeutically engineered red blood cells derived from human peripheral blood stem cells or adult red blood cells. The company's revenue is generated by developing and providing next-generation cell therapy.
Who invested in Westlake Therapeutics
8 investors across 2 rounds
See all investors in Westlake Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Westlake Therapeutics
Who invested in Westlake Therapeutics?
Westlake Therapeutics has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Westlake Therapeutics raised?
Westlake Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Westlake Therapeutics last raise money?
Westlake Therapeutics's most recent round on record is a Series A, in Jun 2022.
What does Westlake Therapeutics do?
, trading as Westlake Therapeutics, is a cell therapy company that focuses on the research and development of blood cell products.
Where is Westlake Therapeutics headquartered?
Westlake Therapeutics is headquartered in Hangzhou, China.
Which VCs invest in companies like Westlake Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Westlake Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Westlake Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.